*ST飛樂(600651.SH):完成轉讓華鑫股份6.63%股權
格隆匯5月29日丨*ST飛樂(600651.SH)公佈,公司採用非公開協議轉讓方式向上海儀電(集團)有限公司(以下簡稱“儀電集團”)出售所持有的上海華鑫股份有限公司(以下簡稱“華鑫股份”)7033.76萬股股票,佔華鑫股份已發行總股本的6.63%。
2020年5月29日,中國證券登記結算有限責任公司出具《過户登記確認書》,華鑫股份7033.76萬股股票已登記至儀電集團賬户。
截至本公告披露日,儀電集團已按照《股份轉讓協議》及《股份轉讓協議之補充協議》的約定向公司支付了全部交易價款9.81億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.